BioRestorative Therapies, Inc. — Form 8-K
Filed August 25, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 21, 2026, BioRestorative Therapies, Inc. received notice of delisting or failure to satisfy continued listing rules/standards (Item 3.01). The filing provides no specific details on which listing standard was breached, the timeline for remediation, or which exchange issued the notice. This represents a critical corporate governance event for the $11.2M market-cap company.
Why this rating
Delisting is existential threat to public company; loss of exchange listing directly threatens access to capital, investor base, and operational viability at this scale.
Extracted items
- 3.01 delisting notice
- 9.01 exhibits
See more from August 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.